# Can a GLP-1 cause low blood sugar?

Source: https://pepvault.app/guides/glp-1-low-blood-sugar

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [GLP-1s](https://pepvault.app/guides#glp1)

# Can a GLP-1 cause low blood sugar if you do not have diabetes?

Reviewed November 2026 13 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

Rarely. In weight-loss trials, readings under 54 mg/dL hit 0.3% on Zepbound and 0.6% on Foundayo, none on placebo. When the risk rises and what to do about it.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 13
- **Questions:** 6
- **Compounds:** 5

## The short answer

Rarely, but it can. In the weight-loss trials of adults without diabetes, a reading under 54 mg/dL showed up in 0.3% on Zepbound and 0.6% on Foundayo, against none on placebo. These drugs push insulin out only while blood sugar is normal or high. Without diabetes, lows cluster around days of barely eating or vomiting, past bariatric surgery, alcohol or too large a dose.

Every number checked at its primary source · Nov 20, 2026 · [13 sources](https://pepvault.app/guides/glp-1-low-blood-sugar#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** FDA prescribing information for Wegovy, Zepbound, Saxenda, Foundayo, Trulicity, Ozempic and Mounjaro (DailyMed, versions current in November 2026) with their placebo-controlled trial data; two small human clamp studies (2002, 2018), one small human study after gastric bypass (2014) and two case reports (2024, 2026); NIDDK's patient guidance on treating a low.

## How often do GLP-1s cause low blood sugar without diabetes?

Seldom, on every label that reports it. **Low blood sugar** (hypoglycemia) means glucose under 70 mg/dL; the Wegovy label calls a reading under 54 mg/dL, about 3.0 mmol/L, clinically significant[1](https://pepvault.app/guides/glp-1-low-blood-sugar#source-1) [13](https://pepvault.app/guides/glp-1-low-blood-sugar#source-13). Here is what the weight-loss labels report for adults and teens without type 2 diabetes, each against its own **placebo** (a dummy injection or pill), as of November 2026:

| Drug and trial | What was counted | Placebo | On the drug |
| --- | --- | --- | --- |
| Zepbound (tirzepatide), Study 1, adults, 72 weeks | Glucose under 54 mg/dL | 0% | 0.3%[2](https://pepvault.app/guides/glp-1-low-blood-sugar#source-2) |
| Foundayo (orforglipron, a daily pill), Trial 1, adults | Glucose under 54 mg/dL | 0% | 0.6%; no severe lows[4](https://pepvault.app/guides/glp-1-low-blood-sugar#source-4) |
| Saxenda (liraglutide), adult trials | Symptoms reported as a low, not confirmed by a reading | 1.1% (19 of 1,729) | 1.6% (46 of 2,962)[3](https://pepvault.app/guides/glp-1-low-blood-sugar#source-3) |
| Saxenda, adult trials | Fasting glucose under 54 mg/dL at a clinic visit | 0.1% | 0.1%[3](https://pepvault.app/guides/glp-1-low-blood-sugar#source-3) |
| Wegovy (semaglutide), SELECT heart trial, about 3 years | Serious lows | 1 episode in 8,801 people | 3 episodes in 8,803 people[1](https://pepvault.app/guides/glp-1-low-blood-sugar#source-1) |
| Saxenda, teens aged 12 to 17, 56 weeks, meters handed out | Under 70 mg/dL with symptoms | 4% | 15.2%[3](https://pepvault.app/guides/glp-1-low-blood-sugar#source-3) |
| Saxenda, the same teens | Under 54 mg/dL | 0.8% | 1.6%; no severe lows[3](https://pepvault.app/guides/glp-1-low-blood-sugar#source-3) |

Read the adult rows as a floor. The Wegovy, Zepbound, Foundayo and Saxenda labels all say their adult trials without diabetes did not systematically capture lows[1](https://pepvault.app/guides/glp-1-low-blood-sugar#source-1) [2](https://pepvault.app/guides/glp-1-low-blood-sugar#source-2) [3](https://pepvault.app/guides/glp-1-low-blood-sugar#source-3) [4](https://pepvault.app/guides/glp-1-low-blood-sugar#source-4); the Saxenda label adds that nobody was given a meter or a diary to look for them[3](https://pepvault.app/guides/glp-1-low-blood-sugar#source-3). The one trial in these labels that did hand out meters, Saxenda's in teenagers, found mild lows nearly four times as often as placebo, while readings under 54 mg/dL stayed under 2% and nobody needed help from another person[3](https://pepvault.app/guides/glp-1-low-blood-sugar#source-3). The pattern across all of them: mild dips are more common than the adult tables show, and serious lows are rare.

<!--promo-->

In PepVault, a shaky spell goes in the side-effect log with its date, a severity from minimal to very severe and a note for the reading, filed under the compound you take. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1-low-blood-sugar-inline&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

In PepVault, a shaky spell goes in the side-effect log with its date, a severity from minimal to very severe and a note for the reading, filed under the compound you take.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Why do GLP-1s rarely push blood sugar too low on their own?

Because their push on insulin switches off as sugar falls. A GLP-1 drug copies **GLP-1**, a gut hormone that asks the pancreas for insulin only while glucose is normal or high (our guide on whether Ozempic is insulin covers that part). Two experiments show where the switch sits.

In 2002, nine healthy volunteers had their blood sugar stepped down on purpose with an insulin drip, once with a GLP-1 drip and once with salt water. GLP-1's extra insulin was negligible below 4.3 mmol/L, about 77 mg/dL. It lowered **glucagon**, the hormone that raises sugar, only at normal sugar; at 3.7 mmol/L (about 67 mg/dL) and below, glucagon climbed just as it did without GLP-1. The other alarm hormones and the warning symptoms rose normally too; only the growth hormone response was smaller[8](https://pepvault.app/guides/glp-1-low-blood-sugar#source-8).

In 2018, 38 people with type 2 diabetes took weekly semaglutide or placebo for 12 weeks each before the same kind of test. Their glucagon response to a low was the same on both, and the drip of sugar needed to hold the low steady was too, though noradrenaline and cortisol rose a little less on semaglutide. Symptom scores at the lowest point were lower on semaglutide, though, and fewer people recognized the low[9](https://pepvault.app/guides/glp-1-low-blood-sugar#source-9). That is a reason to trust a reading over a feeling.

## Why does the risk rise with insulin or a sulfonylurea?

Insulin lowers sugar whatever the level, and a **sulfonylurea** (glipizide, glimepiride, glyburide: older diabetes pills) squeezes insulin out of the pancreas whatever the level too. The GLP-1's brake no longer protects you, and every label warns that the pairing raises the risk of lows, severe ones included[1](https://pepvault.app/guides/glp-1-low-blood-sugar#source-1) [2](https://pepvault.app/guides/glp-1-low-blood-sugar#source-2) [3](https://pepvault.app/guides/glp-1-low-blood-sugar#source-3) [5](https://pepvault.app/guides/glp-1-low-blood-sugar#source-5). Taken alone in diabetes trials, the serious lows vanish: Mounjaro had no reading under 54 mg/dL against 1% on placebo[7](https://pepvault.app/guides/glp-1-low-blood-sugar#source-7), and Ozempic had no severe or confirmed low at or under 56 mg/dL against 1.6% on placebo, though 1.6% and 3.8% on its two doses had a symptomatic reading at or under 70 mg/dL, against none on placebo[6](https://pepvault.app/guides/glp-1-low-blood-sugar#source-6). Trulicity, the dulaglutide pen, is approved only for diabetes, and its label shows the gradient clearly:

| Trulicity (dulaglutide) taken with | Weeks | Placebo | Trulicity, under 54 mg/dL |
| --- | --- | --- | --- |
| Metformin | 26 | 0% | 0.3% at 0.75 mg, 0.7% at 1.5 mg[5](https://pepvault.app/guides/glp-1-low-blood-sugar#source-5) |
| Glimepiride, a sulfonylurea | 24 | 0% | 3.3% at 1.5 mg[5](https://pepvault.app/guides/glp-1-low-blood-sugar#source-5) |
| Basal insulin (glargine) | 28 | 9.3% | 14.7% at 1.5 mg[5](https://pepvault.app/guides/glp-1-low-blood-sugar#source-5) |
| Mealtime insulin | 52 | Not reported | 77% at 0.75 mg, 69% at 1.5 mg[5](https://pepvault.app/guides/glp-1-low-blood-sugar#source-5) |

The weight-loss labels show the same split in their diabetes trials. On Zepbound, 10.3% of people also taking a sulfonylurea had a low under 54 mg/dL, against 2.1% of those not taking one[2](https://pepvault.app/guides/glp-1-low-blood-sugar#source-2). On Foundayo the figures were 7% and 0.5%[4](https://pepvault.app/guides/glp-1-low-blood-sugar#source-4). In the Saxenda diabetes trial, 28.2% of people on a sulfonylurea had one, against 12.7% on placebo, even though their sulfonylurea dose had been halved at the start[3](https://pepvault.app/guides/glp-1-low-blood-sugar#source-3). The labels leave the adjustment to the prescriber, who may lower the insulin or sulfonylurea when the GLP-1 starts[1](https://pepvault.app/guides/glp-1-low-blood-sugar#source-1) [2](https://pepvault.app/guides/glp-1-low-blood-sugar#source-2) [5](https://pepvault.app/guides/glp-1-low-blood-sugar#source-5).

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Growth hormone (GH)](https://pepvault.app/glossary/growth-hormone)
- [Placebo](https://pepvault.app/glossary/placebo)

## What makes a low more likely if you don't have diabetes?

- **Days of barely eating or vomiting.** Case reports describe lows with ketoacidosis (acid build-up from burning fat for fuel) in people without diabetes on tirzepatide: four female patients aged 17 to 34 in Kuwait with vomiting or diarrhea, three of them around week 5 or right after a step-up to 5 mg, with a median glucose under 3.89 mmol/L (70 mg/dL)[11](https://pepvault.app/guides/glp-1-low-blood-sugar#source-11); and a 21-year-old woman in Japan on a low-carb diet whose nausea and vomiting after her fifth injection cut her eating sharply, with a glucose of 68 mg/dL. Her acid build-up cleared within 12 hours on a glucose drip[12](https://pepvault.app/guides/glp-1-low-blood-sugar#source-12). Case reports are the weakest kind of evidence: they show it can happen, not how often.
- **Past bariatric surgery.** The Wegovy label names it a risk factor: in SELECT, 2.3% (2 of 87) of people with that history had a serious low on Wegovy, against none of 97 on placebo[1](https://pepvault.app/guides/glp-1-low-blood-sugar#source-1). After a gastric bypass the gut already releases surges of GLP-1 after meals, and blocking the GLP-1 receptor corrected post-meal lows in all nine patients with them in one study[10](https://pepvault.app/guides/glp-1-low-blood-sugar#source-10). Our guide to a GLP-1 after bariatric surgery covers the rest.
- **Alcohol.** Our guide to alcohol on a GLP-1 covers how drinking adds to the risk of a low.
- **Too large a dose.** The Wegovy and Saxenda labels list severe low blood sugar among the effects of overdoses with GLP-1 drugs[1](https://pepvault.app/guides/glp-1-low-blood-sugar#source-1) [3](https://pepvault.app/guides/glp-1-low-blood-sugar#source-3).

## Is feeling shaky on a GLP-1 a sign of low blood sugar?

Sometimes. The Zepbound label's signs of a low are dizziness or light-headedness, sweating, confusion or drowsiness, headache, blurred vision, slurred speech, shakiness, a fast heartbeat, anxiety or irritability, hunger, weakness and feeling jittery[2](https://pepvault.app/guides/glp-1-low-blood-sugar#source-2). Several of those also come with eating far less and with dehydration from nausea, so the feeling alone does not settle it. A finger-stick meter or a glucose sensor does: under 70 mg/dL with symptoms is a low, under 54 mg/dL is a clinically significant one[1](https://pepvault.app/guides/glp-1-low-blood-sugar#source-1) [13](https://pepvault.app/guides/glp-1-low-blood-sugar#source-13).

No label gives the week in which lows start, because the trials without diabetes did not look for them[1](https://pepvault.app/guides/glp-1-low-blood-sugar#source-1) [2](https://pepvault.app/guides/glp-1-low-blood-sugar#source-2) [4](https://pepvault.app/guides/glp-1-low-blood-sugar#source-4). The case reports above cluster in the first weeks and around a step-up, the same stretch in which the Zepbound label places most nausea and vomiting[2](https://pepvault.app/guides/glp-1-low-blood-sugar#source-2) [11](https://pepvault.app/guides/glp-1-low-blood-sugar#source-11) [12](https://pepvault.app/guides/glp-1-low-blood-sugar#source-12).

**Commonly reported:** shaky, sweaty or light-headed spells on a day of eating very little, most often in the first weeks or just after a dose step-up, easing once the person eats. On our reports page, 2 of the 77 tirzepatide write-ups name low blood sugar, and some of those posters have diabetes.

<!--promo-->

PepVault's food log sets one daily target, protein first, so a day when appetite barely lets you eat shows up on the plate instead of only in how you feel. [Track your food in PepVault](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-glp-1-low-blood-sugar-inline&mt=8)

<!--/promo-->

## What do you do if your blood sugar runs low?

The NIH's diabetes institute (NIDDK) gives the standard steps for a reading under 70 mg/dL, or symptoms with a reading below your target[13](https://pepvault.app/guides/glp-1-low-blood-sugar#source-13):

1. Eat or drink 15 to 20 grams of fast sugar right away: four glucose tablets, one tube of glucose gel, half a cup (4 ounces) of regular fruit juice, 4 to 6 ounces of regular soda, or a tablespoon of sugar or honey[13](https://pepvault.app/guides/glp-1-low-blood-sugar#source-13).
2. Wait 15 minutes, then check again[13](https://pepvault.app/guides/glp-1-low-blood-sugar#source-13).
3. Still low? Take another 15 to 20 grams and check after another 15 minutes, until you are back in range[13](https://pepvault.app/guides/glp-1-low-blood-sugar#source-13).
4. If your next meal is more than an hour away, have a snack such as crackers or a piece of fruit[13](https://pepvault.app/guides/glp-1-low-blood-sugar#source-13).
5. Write down the time, the reading and what you had eaten that day, and tell your prescriber; whether a dose changes is their decision.

**When to get help** A low with confusion, fainting or a seizure, or one you cannot treat because you cannot eat or keep food down, needs emergency care right away[13](https://pepvault.app/guides/glp-1-low-blood-sugar#source-13).

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. WEGOVY (semaglutide) injection and tablets prescribing information, Novo Nordisk, DailyMed (SPL version 19), June 2026 [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b)
2. ZEPBOUND (tirzepatide) injection prescribing information, Eli Lilly, DailyMed (SPL version 40), August 2026 [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b)
3. SAXENDA (liraglutide) injection prescribing information, Novo Nordisk, DailyMed (SPL version 22), 2026 [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3946d389-0926-4f77-a708-0acb8153b143)
4. FOUNDAYO (orforglipron) tablets prescribing information, Eli Lilly, DailyMed (SPL version 10), July 2026 [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62)
5. TRULICITY (dulaglutide) injection prescribing information, Eli Lilly, DailyMed (SPL version 62), June 2026 [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=463050bd-2b1c-40f5-b3c3-0a04bb433309)
6. OZEMPIC (semaglutide) injection prescribing information, Novo Nordisk, DailyMed (SPL version 20), June 2026 [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79)
7. MOUNJARO (tirzepatide) injection prescribing information, Eli Lilly, DailyMed (SPL version 40), August 2026 [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0)
8. Nauck MA et al. Effects of glucagon-like peptide 1 on counterregulatory hormone responses, cognitive functions, and insulin secretion during hyperinsulinemic, stepped hypoglycemic clamp experiments in healthy volunteers. J Clin Endocrinol Metab. 2002;87(3):1239-46. [PubMed 11889194](https://pubmed.ncbi.nlm.nih.gov/11889194/)
9. Korsatko S et al. Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: a randomized, placebo-controlled, double-blind, crossover trial. Diabetes Obes Metab. 2018;20(11):2565-2573. [PubMed 29893488](https://pubmed.ncbi.nlm.nih.gov/29893488/)
10. Salehi M, Gastaldelli A, D'Alessio DA. Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass. Gastroenterology. 2014;146(3):669-680. [PubMed 24315990](https://pubmed.ncbi.nlm.nih.gov/24315990/)
11. Bitar Z et al. Exploring hypoglycemic ketoacidosis in nondiabetic patients on tirzepatide: is starvation the culprit? Am J Case Rep. 2024;25:e946133. [PubMed 39686534](https://pubmed.ncbi.nlm.nih.gov/39686534/)
12. Minoda Y et al. Starvation ketoacidosis associated with tirzepatide use for weight loss in a non-diabetic East Asian woman: a case report. Int J Emerg Med. 2026;19(1):119. [PubMed 41840480](https://pubmed.ncbi.nlm.nih.gov/41840480/)
13. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Low blood glucose (hypoglycemia). Last reviewed July 2021. [niddk.nih.gov](https://www.niddk.nih.gov/health-information/diabetes/overview/preventing-problems/low-blood-glucose-hypoglycemia)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · GLP-1

Guide · GLP-1

### [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)

No medicine is approved for GLP-1 nausea yet. Tradipitant, a motion-sickness pill, cut vomiting after semaglutide in phase 3. What it does, and what helps now.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [Semaglutide Studied range: 0.25–2.4 mg](https://pepvault.app/peptides/semaglutide)
- [Tirzepatide Studied range: 2.5–15 mg](https://pepvault.app/peptides/tirzepatide)
- [Liraglutide Studied range: 0.6–3 mg](https://pepvault.app/peptides/liraglutide)
- [Dulaglutide Studied range: 0.75–4.5 mg](https://pepvault.app/peptides/dulaglutide)
- [Orforglipron Studied range: 0.8–17.2 mg](https://pepvault.app/peptides/orforglipron)

## Related guides

- Guide · GLP-1s

  ### [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)

  No. Ozempic and Mounjaro copy gut hormones, GLP-1 and GIP, that make your own pancreas release insulin only when blood sugar is high. Here is how that differs.

  Read the guide
- Guide · GLP-1s

  ### [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)

  Do GLP-1s work after a gastric sleeve or bypass? The trials on regain, the labels' doses side by side, side effects after surgery, and sleeve vs GLP-1 numbers.

  Read the guide
- Guide · GLP-1s

  ### [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)

  None of the four labels mentions drinking. Where alcohol matters on Ozempic, Wegovy, Mounjaro or Zepbound, and what the alcohol trials of semaglutide found.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Tirzepatide

- [Tirzepatide: the full reference](https://pepvault.app/peptides/tirzepatide)
- [Tirzepatide dose guide](https://pepvault.app/lab/dosage/tirzepatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)
- [Tirzepatide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-5mg)
- [Tirzepatide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-10mg)
- [Tirzepatide 15 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-15mg)
- [Tirzepatide 30 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-30mg)
- [Tirzepatide 60 mg vial](https://pepvault.app/tools/reconstitution-calculator/tirzepatide-60mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Tirzepatide plus apitegromab: 1.9 kg less lean mass loss in EMBRAZE](https://pepvault.app/research/tirzepatide-embraze-2026)
- [Tirzepatide SURMOUNT-MAINTAIN: 21.9% weight loss at 112 weeks](https://pepvault.app/research/tirzepatide-surmount-maintain-2026)
- [Dulaglutide: switching to tirzepatide beat dose escalation on HbA1c](https://pepvault.app/research/dulaglutide-surpass-switch-2025)
- [All 19 studies](https://pepvault.app/research#tirzepatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### The GLP-1 path

- [Retatrutide week by week](https://pepvault.app/guides/retatrutide-week-by-week)
- [Retatrutide dosage: the trial step-ups](https://pepvault.app/guides/retatrutide-dosage-in-trials)
- [Tirzepatide week by week](https://pepvault.app/guides/tirzepatide-week-by-week)
- [Semaglutide week by week](https://pepvault.app/guides/semaglutide-week-by-week)
- [Tirzepatide dosage: every step from 2.5 to 15 mg (Mounjaro and Zepbound)](https://pepvault.app/guides/tirzepatide-dosage)
- [Wegovy and Ozempic dosage: both labels' steps in one table, and why the two differ](https://pepvault.app/guides/wegovy-and-ozempic-dosage)
- [How to use the Zepbound KwikPen](https://pepvault.app/guides/how-to-use-the-zepbound-kwikpen)
- [How to use the Ozempic and Wegovy pens: needles, the dose counter and clicks](https://pepvault.app/guides/how-to-use-ozempic-and-wegovy-pens)
- [What time of day to take your GLP-1 shot or pill, and can you change the day?](https://pepvault.app/guides/when-to-take-your-glp-1)
- [Switching GLP-1s: Ozempic to Zepbound, shot to pill, and what the trials tested](https://pepvault.app/guides/switching-between-glp-1s)
- [Ozempic vs Wegovy vs Mounjaro vs Zepbound: the four labels in one table](https://pepvault.app/guides/ozempic-wegovy-mounjaro-zepbound)
- [Is Ozempic insulin? GLP-1, GIP and insulin explained](https://pepvault.app/guides/is-ozempic-insulin)
- [The Wegovy pill: what it is, how its label differs from the shot, and the trial numbers](https://pepvault.app/guides/the-wegovy-pill)
- [Ozempic and Wegovy side effects: what the trials counted and when they showed up](https://pepvault.app/guides/ozempic-and-wegovy-side-effects)
- [Semaglutide vs tirzepatide side effects: what the head-to-head trials found](https://pepvault.app/guides/sema-vs-tirzepatide-side-effects)
- [Microdosing a GLP-1: what it means and what has been tested](https://pepvault.app/guides/microdosing-a-glp-1)
- [GLP-1s and sleep apnea: Zepbound's OSA approval](https://pepvault.app/guides/glp-1-and-sleep-apnea)
- [Retatrutide first dose: the first four weeks in the trials](https://pepvault.app/guides/retatrutide-first-dose)
- [Retatrutide side effects: what the trials counted](https://pepvault.app/guides/retatrutide-side-effects)
- [Retatrutide not working? Stalls, slow responders and the plateau](https://pepvault.app/guides/retatrutide-not-working)
- [Switching from tirzepatide to retatrutide: what is known](https://pepvault.app/guides/tirzepatide-to-retatrutide)
- [Is retatrutide safe? What the trials reported](https://pepvault.app/guides/is-retatrutide-safe)
- [When will retatrutide be approved?](https://pepvault.app/guides/when-will-retatrutide-be-approved)
- [TRIUMPH-5 results: retatrutide vs tirzepatide head to head](https://pepvault.app/guides/triumph-5-results)
- [CagriSema FDA approval: when it's due, the dose filed, and what the trials showed](https://pepvault.app/guides/cagrisema-fda-decision)
- [MariTide phase 3 results (MARITIME-1): what to expect](https://pepvault.app/guides/maritime-1-results)
- [Aleniglipron: the GLP-1 pill, and the trial switching people from shots to it](https://pepvault.app/guides/aleniglipron-switch-trial)
- [Mounjaro and Zepbound side effects by dose: the rates at each step](https://pepvault.app/guides/mounjaro-zepbound-side-effects)
- [Hair loss on a GLP-1: how common it is per drug, and why](https://pepvault.app/guides/hair-loss-on-a-glp-1)
- ["Ozempic face": what it is, and where the weight comes from](https://pepvault.app/guides/ozempic-face)
- [Foundayo (orforglipron) vs the shots: the trial numbers side by side](https://pepvault.app/guides/foundayo-vs-the-shots)
- [Is compounded semaglutide or tirzepatide the same as Ozempic or Zepbound?](https://pepvault.app/guides/compounded-glp-1-vs-brand)
- [Why compounded semaglutide and tirzepatide come with B12, glycine or B6, and what it changes](https://pepvault.app/guides/compounded-glp-1-with-b12)
- [Is there a generic Ozempic? Generic semaglutide and Sevmia](https://pepvault.app/guides/generic-semaglutide)
- [How much does a GLP-1 cost in 2026? Zepbound, Wegovy and Medicare prices](https://pepvault.app/guides/how-much-does-a-glp-1-cost)
- [What to eat on a GLP-1: what the trials and the guidelines say](https://pepvault.app/guides/what-to-eat-on-a-glp-1)
- [How much protein per day? The numbers by weight and goal](https://pepvault.app/guides/how-much-protein-per-day)
- [Muscle on a GLP-1: how much of the weight lost is lean mass?](https://pepvault.app/guides/muscle-on-a-glp-1)
- [Intermittent fasting on a GLP-1: what the trials and labels say](https://pepvault.app/guides/intermittent-fasting-on-a-glp-1)
- [Coffee on a GLP-1: can you drink it, and why it can taste different](https://pepvault.app/guides/coffee-on-a-glp-1)
- [Food noise on a GLP-1: what it is and what happens after stopping](https://pepvault.app/guides/food-noise-on-a-glp-1)
- [GLP-1s and menopause: what the trials say about women in midlife](https://pepvault.app/guides/glp-1s-and-menopause)
- [Stopping a GLP-1: what happens to your weight](https://pepvault.app/guides/stopping-a-glp-1)
- [How to keep the weight off after a GLP-1: what each trial tested](https://pepvault.app/guides/keeping-weight-off-after-a-glp-1)
- [Berberine vs metformin vs a GLP-1: what each does to weight and glucose](https://pepvault.app/guides/berberine-vs-metformin-vs-glp-1)
- [Natural GLP-1 alternatives: what the evidence shows for berberine, fiber and supplements](https://pepvault.app/guides/natural-glp-1-alternatives)
- [What is 5-Amino-1MQ? What's been measured](https://pepvault.app/guides/5-amino-1mq-explained)
- [Retatrutide from a lab vial: what independent testing found](https://pepvault.app/guides/retatrutide-lab-vial-tests)
- [Switching from Saxenda to Wegovy: how the change works](https://pepvault.app/guides/saxenda-to-wegovy)
- [Do you stop Ozempic, Wegovy, Mounjaro or Zepbound before surgery?](https://pepvault.app/guides/glp-1-before-surgery)
- [Diarrhea on a GLP-1: how common, and how long it lasts](https://pepvault.app/guides/diarrhea-on-a-glp-1)
- [Dizziness on a GLP-1: dehydration, blood pressure or blood sugar?](https://pepvault.app/guides/dizziness-on-a-glp-1)
- [Heartburn and acid reflux on a GLP-1: the rates, the timing and what helps](https://pepvault.app/guides/heartburn-on-a-glp-1)
- [Does Ozempic or Mounjaro make you tired? Fatigue in the trials](https://pepvault.app/guides/glp-1-fatigue)
- [Is there a medicine for GLP-1 nausea? Tradipitant, so far](https://pepvault.app/guides/tradipitant-for-glp-1-nausea)
- [GLP-1s and mood: depression, anxiety and what the FDA review found](https://pepvault.app/guides/glp-1s-and-mood)
- [Can Ozempic cause vision loss? GLP-1s and NAION, by the numbers](https://pepvault.app/guides/glp-1-and-naion)
- [Are GLP-1s safe long term? What the longest trials show](https://pepvault.app/guides/are-glp-1s-safe-long-term)
- [GLP-1s and the kidneys: what FLOW showed, and the dehydration risk](https://pepvault.app/guides/glp-1s-and-the-kidneys)
- [Can you drink alcohol on Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/alcohol-on-a-glp-1)
- [Do GLP-1s reduce alcohol cravings? What the trials found](https://pepvault.app/guides/glp-1-and-alcohol-cravings)
- [GLP-1s and fatty liver: what the trials measured](https://pepvault.app/guides/glp-1-and-fatty-liver)
- [GLP-1s after a gastric sleeve or bypass: regain, dosing and sleeve vs GLP-1](https://pepvault.app/guides/glp-1-after-bariatric-surgery)
- [Can you drink alcohol on retatrutide?](https://pepvault.app/guides/retatrutide-and-alcohol)
- [Ozempic, Wegovy, Mounjaro or Zepbound not working? Slow responders and plateaus in the trials](https://pepvault.app/guides/glp-1-not-working)
- [Intermittent fasting for weight and fat loss: what the trials measured](https://pepvault.app/guides/intermittent-fasting-weight-loss)
- [Can you take metformin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/metformin-with-a-glp-1)
- [GLP-1s and pregnancy: Ozempic, Wegovy, Mounjaro and Zepbound before and during](https://pepvault.app/guides/glp-1s-and-pregnancy)
- [Can you take Ozempic, Mounjaro or another GLP-1 while breastfeeding?](https://pepvault.app/guides/glp-1-while-breastfeeding)
- [Eloralintide, petrelintide and amycretin: the amylin drugs in trials](https://pepvault.app/guides/amylin-drugs-in-trials)
- [Olatorepatide (HS-20094): Regeneron's obesity drug, what is known so far](https://pepvault.app/guides/olatorepatide-explained)
- [Cagrilintide and CagriSema: what amylin adds to semaglutide](https://pepvault.app/guides/cagrilintide-and-cagrisema)
- [Berobenatide (PF-08653944, MET-097i): Pfizer's monthly GLP-1 shot, what is known so far](https://pepvault.app/guides/berobenatide-explained)
- [The GLP-1 pipeline: every drug in phase 2 and 3, and when its trials finish](https://pepvault.app/guides/glp-1-pipeline)
- [Is there a monthly GLP-1 shot? MariTide and berobenatide](https://pepvault.app/guides/monthly-glp-1-shots)
- [Cagrilintide alone: RENEW 1 phase 3 results and what to expect](https://pepvault.app/guides/renew-1-cagrilintide-results)
- [Wegovy HD: is 7.2 mg worth it, and what changes from 2.4 mg](https://pepvault.app/guides/wegovy-hd-7-2-mg)
- [Zenagamtide (amycretin): Novo's GLP-1 and amylin shot and pill, what the trials show](https://pepvault.app/guides/zenagamtide-amycretin)
- [Wegovy and Ozempic price, Medicare and WADA: what changes on January 1, 2027](https://pepvault.app/guides/glp-1-changes-january-2027)
- [Can you take sermorelin with Ozempic, Mounjaro or another GLP-1?](https://pepvault.app/guides/sermorelin-with-a-glp-1)
- [Retatrutide in women: what the studies included](https://pepvault.app/guides/retatrutide-in-women)
- [Peptides for women: what the trials in women show, and after 40](https://pepvault.app/guides/peptides-for-women)
- [Low-dose naltrexone (LDN) for weight loss: what the trials measured](https://pepvault.app/guides/ldn-for-weight-loss)
- [GLP-1s and PCOS: what the trials show, and how they compare with metformin](https://pepvault.app/guides/glp-1-and-pcos)
- [GLP-1s and sleep: insomnia, vivid dreams and the sleep apnea approval](https://pepvault.app/guides/glp-1s-and-sleep)

### Terms on this page

- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Growth hormone (GH)](https://pepvault.app/glossary/growth-hormone)
- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?ppid=616838ec-3248-400f-bd58-4b93f85f1a20&pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
